Friedreich Ataxia

This is a rare genetic disease that affects the nervous system. It usually starts in childhood and causes problems with movement, like walking. It can also affect speech, heart function, and spine shape. It's caused by a change in a specific gene.

Condition

What people with Friedreich Ataxia report

Every report comes from a Lived member, sent anonymously.

Have you tried Exercise Therapy for Friedreich Ataxia?

NameHow it went

About Friedreich Ataxia

What It Is

Friedreich ataxia (FA) is a rare inherited condition that gradually damages the nervous system. It mainly affects nerve fibers in the spinal cord, the nerves that carry sensation and movement signals to the arms and legs, and the cerebellum, the part of the brain that coordinates balance and movement. The central symptom is ataxia, meaning trouble coordinating movement, and it worsens over time. The first signs are usually unsteady walking, poor balance and clumsiness. Over the years people may also notice loss of feeling in the feet and hands, loss of reflexes, weakness, muscle stiffness, slurred speech, trouble swallowing, hearing or vision changes, and fatigue. FA is not only a nerve condition: many people develop thickening of the heart muscle (cardiomyopathy), which can lead to heart failure or rhythm problems, and some develop diabetes or a curved spine (scoliosis). Symptoms usually begin between ages 5 and 15, but about a quarter of people first notice them after age 25, and later-onset forms tend to progress more slowly. FA affects roughly 1 in 40,000 people in the United States and is the most common inherited ataxia in the country.

Causes & Risk Factors

FA is caused by changes in a gene called FXN, which carries instructions for frataxin, a protein that mitochondria (the energy-producing parts of cells) need to work properly. In most people with FA, a short three-letter stretch of DNA called a GAA repeat is copied far more times than normal: usually 5 to 33 times, but 66 to more than 1,000 times in FA. This expansion sharply cuts how much frataxin the body makes. Nerve cells, spinal cord cells and heart muscle cells are especially sensitive to the shortage, which is why those systems are most affected. FA is inherited in an autosomal recessive pattern. A person develops it only after inheriting an altered FXN gene from each parent. Someone with one altered copy is a carrier: carriers do not develop FA but can pass the gene on, so the condition often appears in a family with no known history of it. Nothing a person or their parents did causes FA. The length of the repeat matters. Longer repeats are linked with earlier onset, more severe symptoms and faster progression, and shorter ones with later onset. Even so, the repeat size cannot predict exactly when symptoms will start or how a particular person's condition will unfold. FA is most often found in people of European, Middle Eastern, South Asian or North African ancestry.

How It's Diagnosed

A diagnosis usually starts with a neurological examination. A clinician looks for poor balance, loss of sensation, absent reflexes in the knees and ankles, and other signs that point to damage in the spinal cord and peripheral nerves, along with a medical and family history. A genetic blood test confirms FA by finding the expanded GAA repeat in both copies of the FXN gene. Less commonly, a person has the repeat on one copy and a different change on the other, which needs more detailed testing. A genetic counselor can explain the results and what they mean for parents, brothers and sisters, and future children. Other tests help rule out look-alike conditions and set a starting point for care. Nerve conduction studies and electromyography (EMG) measure how well nerves and muscles carry electrical signals. An MRI can show thinning of the spinal cord or cerebellum and exclude other causes. Because the heart is often involved, an electrocardiogram (ECG), which records the heart's rhythm, and an echocardiogram, an ultrasound of the heart's structure and pumping, are done at diagnosis. Blood tests check blood sugar and vitamin E levels. Specialists may use standardized rating scales, such as the modified Friedreich's Ataxia Rating Scale (mFARS), to measure severity and track change over time.

Treatment Options

There is currently no cure for FA, but treatment can slow some of its effects, manage complications and help people stay active and independent for as long as possible. Care works best with a team that may include a neurologist, cardiologist, physical, occupational and speech therapists, and diabetes and orthopedic specialists. Omaveloxolone (Skyclarys) became the first FDA-approved medicine for FA in 2023, for people aged 16 and older. It is a once-daily capsule that switches on a pathway cells use to defend against oxidative stress (damage from reactive by-products of energy production in the mitochondria), although exactly how it helps in FA is not known. In a 48-week trial of people aged 16 to 40, those taking it showed less worsening than those on placebo on the mFARS rating, which scores balance, arm and leg coordination, and speech and swallowing. In other words, their condition declined more slowly over about a year; it does not reverse existing symptoms. It needs regular blood tests of liver function, cholesterol and BNP (a marker of strain on the heart), especially in the first months. It can make hormonal birth control such as pills, patches, rings and implants less reliable, so people using these should switch to a non-hormonal method or add one such as condoms while taking it and for 28 days after stopping. Headache, nausea, stomach pain, tiredness and diarrhea are common side effects, and some other medicines interact with it, so a prescriber should review everything a person takes. Rehabilitation is a core part of treatment. Guidelines suggest regular endurance and strengthening exercise, started and increased gradually, including for people with heart changes. Physical and occupational therapy, braces for the ankles and feet, walkers and properly fitted wheelchairs support mobility and daily tasks. Speech therapy helps with speech and safer swallowing, and hearing aids can help with hearing loss. Complications are treated as they appear. Diabetes is managed with insulin or other glucose-lowering medicines. When the heart's pumping weakens, standard heart failure medicines are used, and rhythm problems may need medicine or a procedure. For scoliosis, bracing during the growth years of about 10 to 16 may help delay or avoid surgery, and surgery may be considered for severe curves. Because FA affects the heart, a cardiologist should evaluate it before any major operation. Depression and anxiety are treated with counseling and, when helpful, medicine. Research, including gene therapy, is ongoing, and some people join clinical trials.

What to Expect

FA is progressive, but its pace varies widely. Many people with typical childhood-onset FA come to need a wheelchair within about 10 to 20 years of their first symptoms, and in later stages they may need help with most daily activities. People whose symptoms begin later often progress more slowly. Heart disease is the most common cause of death in FA, and life expectancy depends heavily on how the heart is affected. Some people with milder forms live into their sixties or beyond. Regular monitoring is a large part of living with FA. Guidelines recommend an ECG and an echocardiogram at least once a year, plus yearly diabetes screening with a fasting blood sugar test and an HbA1c test, which reflects average blood sugar over the past few months. Routine checks of hearing, balance, swallowing, the spine, bone health and mood are also part of good care, and they help the team adjust therapy and equipment as needs change. Daily life often involves planning around fatigue, mobility and the extra time tasks can take. Many people continue school, work, relationships and family life with accommodations, assistive technology and home adaptations. Adjusting to a progressive condition can bring periods of depression or anxiety, and regular check-ins and counseling are recommended. Organizations such as the Friedreich's Ataxia Research Alliance and the National Ataxia Foundation connect families with information, support and research opportunities. Pregnancy is possible for many women with FA. Women whose heart pumping function is reduced, or who have had heart failure, face higher risks for themselves and the baby and should plan pregnancy with a cardiologist and obstetrician. A partner can have carrier testing beforehand to clarify the chance of passing FA to a child.

When to Seek Help

See a doctor for an evaluation if a child or adult develops worsening clumsiness, unsteady walking, frequent falls or slurred speech, especially if a family member has FA. Brothers and sisters of someone with FA can ask about genetic testing and a heart check even without symptoms. Contact the care team promptly about a racing, pounding or irregular heartbeat, dizziness, or signs the heart may be struggling, such as swollen ankles or legs, sudden weight gain (3 pounds or more in a day or 5 pounds or more in a week) or new breathlessness. Mention unusual thirst, frequent urination or unexplained weight loss soon, since these can signal diabetes. Choking or coughing during meals, and low mood that does not lift, are also worth raising before the next routine visit. Fainting (passing out, not a fall from unsteadiness), chest pain or severe difficulty breathing needs emergency care, because in FA these can signal a dangerous heart rhythm or heart failure.

Questions to Ask Your Doctor

  1. 1.What do my genetic results show, and what do they suggest about how my FA may progress?
  2. 2.How often should my heart be checked, and which heart symptoms should make me call between visits?
  3. 3.Is omaveloxolone (Skyclarys) a reasonable option for me, and what monitoring would it involve?
  4. 4.Which therapies, exercises and equipment would help me stay as independent as possible right now?
  5. 5.Are there clinical trials that would make sense for me at this stage, and how would joining one affect my current care?

Last reviewed • Oct 2026

Educational content, not medical advice.